Venture Capital

China Automotive Systems' new high-torque motor isn't just a component; it's a strategic play for the future of autonomous trucking and a challenge to incumbents.

Immatics just secured $125M. This cash infusion is a major bet on its pioneering PRAME-targeted therapies and a key signal for the future of oncology.

A bioengineering firm is tapping deceased donors for bone marrow, promising to end shortages and improve outcomes. Is this the future of transplant medicine?

Kayou's aggressive push into Southeast Asia's collectibles market reveals a sophisticated strategy built on digital networks and hyper-local engagement.

The landmark partnership validates China's biotech prowess and injects Takeda's pipeline with next-gen cancer therapies, signaling a major industry shift.

With new funding, Japan's Helical Fusion is racing to build a fusion plant by the 2030s. Can its unique stellarator technology win the clean energy race?

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

Bitwise appoints a new data VP amid a frenzied AI market. But can one leader bridge the gap between massive spending and measurable business results?

Beyond the hype of air taxis, one Oregon firm is electrifying aviation's workhorses, from firefighting helicopters to military vehicles, in extreme conditions.

A new luxury A-frame in Missouri wine country did more than just build a rental; it invested $2M into local artisans, creating a new model for tourism.

How one tech leader is redefining corporate giving by empowering its employees to direct philanthropy, creating authentic community impact and a new business model.

MicroCloud Hologram is betting $400M on a quantum-driven 3D model. Is it a revolutionary leap for digital creation or a costly gamble on unproven tech?

A new partnership between Pellera Technologies and the NY Rangers is more than a sponsorship. It's a strategic play on heritage, B2B marketing, and community.

A regulatory filing shows hedge fund Balyasny's active trading in Avadel Pharma, exposing a merger arbitrage strategy amid a fierce bidding war.

With AI creating a data center power crisis, one company's safer, greener nickel-zinc batteries are attracting major investment. Here's why it matters.

An award-winning conservation group is turning holiday shopping into a revenue stream for reef restoration. Is this the future of environmental funding?

The battery innovator secures fresh capital to scale its 'One-Pot' process. We analyze if this move signals a turning point for investors and the EV market.

A strategic investment and nationwide rollout of SOTA Cloud's imaging platform across 1,000+ practices signal a new era of integrated dental-medical data.

A new AI-powered platform, CrossSight, promises to deliver audit-ready due diligence reports in minutes, tackling critical third-party security risks.

A new brand enters the eco-friendly cleaning market, betting that PhD-backed science can finally solve the consumer trust gap and prove 'green' can be powerful.